Press Briefing: Office of the Vice Chancellor MUK 6 th September 2010 The Infectious Diseases Institute Care and Research Initiatives Dr Alex G Coutinho.

Slides:



Advertisements
Similar presentations
Follow-up after training and supportive supervision The IMAI District Coordinator Course.
Advertisements

Absorption, Retention and Empowerment
Rakai Health Sciences Program (RHSP) Uganda Population-based Research on HIV, other Infectious Diseases, Reproductive Health and Service delivery.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
Task-Shifting in HIV/AIDS Care in a Rural District of Malawi Some successes and lessons learnt from Thyolo Moses Massaquoi, Rony Zachariah, Ulrike von.
Joshua Kayiwa INRUD-IAA, Uganda. Session Objectives Narrate the experience of the Uganda INRUD-IAA team in collecting, cleaning, summarizing and analyzing.
Late-outcomes of TB-IRIS William Worodria, MBChB, MMed, PhD Senior EDCTP Fellow Infectious Disease Institute, Kampala, Uganda Mulago Hospital & Complex,
Most deaths among children enrolled in two program settings in Cambodia occur within the first 6 months after enrolment. Early mortality rates were more.
Costs and Outcomes of AIDS Treatment Delivery Models Sydney Rosen ab, Lawrence Long b, Ian Sanne bc a Center for International Health and Development,
Stable Outcomes and Costs in South African Patients’ Second Year on Antiretroviral Treatment Lawrence Long, Health Economics Research Office, Wits Health.
Using Nurses to Support Rapid ART Scale up in Zambia Mary Morris Nursing and QA/QC Coordinator Centre for Infectious Disease Research in Zambia (CIDRZ)
Uptake of antiretrovirals in a cohort of women involved in high risk sexual behaviour in Kampala, Uganda J.Bukenya, M. Kwikiriza, O. Musana, J. Ssensamba,
Prevention with Positives; Using Multiple Strategies to Involve Persons Living with HIV in Prevention. TASO Uganda. Emmanuel Odeke,
Establishment of Routine HIV Counseling & Testing at Mulago & Mbarara Teaching Hospitals, Uganda: Acceptability & Lessons Learned IAS Conference Wednesday,
Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.
Effects of Patient Tracking Systems and Providers Incentives on Patient Appointment Keeping Rwanda Pilot Study Report Nyamusore Jose 1 *, Hinda Ruton 1,
Assessing & Improving Quality of Care Newly Developed Quality of Care Tools President’s Emergency Plan for AIDS Relief Track 1.0 ART Program Meeting Seema.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
1 Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Quality Assessment and Improvement Harvard – PEPFAR Tanzania, Nigeria and Botswana.
Integrated Health Programs for Women and Children: Lessons from the Field Dr. Ambrose Misore Project Director, APHIA II Western, PATH’s Kenya Country Program.
IMAI Sequence of Care Task shifting, division of labor, and the role of non-clinicians on the care team.
Management and Development for Health (MDH)
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
Office of Overseas Programming & Training Support (OPATS) Treatment Adherence HIV Care, Support, and Treatment.
Dr. Hind E. Satti Partners In Health, Lesotho March, 2008.
Best practice and innovations by PHAs in accessing and supporting rural HIV/AIDS programmes in Uganda Dr Joanita Kigozi College of Health Sciences, Makerere.
Ministry of Health, Mozambique
Orientation on HIV care and ART Recording and Reporting System.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
Charles S. Kiptemas, MBChB, MPH Director South Rift Valley HIV Care & Treatment Program Kenya Medical Research Institute/Walter Reed Project Track 1 Partners.
Efficacy of routine viral load, CD4 cell count, and clinical monitoring of adults taking antiretroviral therapy in Rural Uganda Alex Coutinho MD MPH DTM&H.
President’s Emergency Plan for AIDS Relief 2006 Semi-Annual Program Results (SAPR) October 1, 2005 – March 31, 2006.
Use of Routine Feedback Reports to Site and District Staff in Cote d’Ivoire Hermann Brou Annual Meeting, M&E satellite meeting Johannesburg, July 28, 2010.
Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases.
Integration of TB and HIV Screening, Care and Treatment in Mulago Hospital, Uganda Rhoda Wanyenze, Doris Mwesigire, Henry Luzze, Violet Gwokyalya, Julius.
Sub module 1 Introduction to HIV care and ART recording and reporting system.
Objective The overall aim of this research is to develop statistical and mathematical models for CD4 trajectories and co-infection pattern of TB and HIV.
Working with Non-Governmental Agencies: Our African Experience Dr Jack Watters Vice President External Medical Affairs, International Pfizer (EMAI)
Sub module 3 Pre-ART and ART registers. Purpose of registers Key individual information for: Facilitating patient management by the identification of.
Antiretroviral treatment programme in Thyolo district, Malawi Southern Region. MSF Luxembourg & Thyolo District Health Services - Strategic information.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
TB and HIV integrated services at Martin Preuss Centre in Lilongwe, Malawi : “The Lighthouse Trust initiative” Dr Sam Phiri Executive Director Lighthouse.
Figure 2: Trends in currently prescribed antiretroviral therapy % prescribed HAART increased from 74% to 83% Trends in ART use, HIV viral load, and CD4.
WAD SYMPOSIUM 2014 ART Adherence and Retention: MDH Experience Eric Aris Management and Development for Health 29 th November 2014 NJOMBE.
MATERNAL ANTIRETROVIRAL THERAPY AND INFANT OUTCOMES THROUGHOUT THE FIRST YEAR OF LIFE: results from the DREAM study in Dschang, Cameroon Taafo F, Doro.
1 Uses of Data from the WHO HIV Drug Resistance Strategy: 1. Monitoring of HIVDR emerging in treated groups in sentinel ART clinics HIV Drug Resistance.
STATE OF THE EPIDEMIC AND THE RESPONSE PROMISES, PROGRESS AND PROBLEMS DR. ALEX COUTINHO MD MPH Executive Director Infectious Diseases Institute.
From Aggregate Indicators to Impacting Patients - Data Use to Inform Treatment and Improve Care Ian Wanyeki Track 1.0 Implementers Meeting Dar Es Salaam.
Improving Patients Retention in Antiretroviral Treatment Programs: The experience of ARV Programs in Côte d’Ivoire Eugène MESSOU, MD, PhD CePReF- Aconda.
1 Predictors of Immunological Failure Among Adult Patients Receiving ART at an urban, HIV Clinic in Uganda Dr. Muhumuza Simon (M.D, MPH) Mulago-Mbarara.
Discontinuation from community-based antiretroviral adherence clubs in Gugulethu, Cape Town, South Africa Andile Nofemela, Cathy Kalombo, Catherine Orrell,
Joseph Kibachio4, William Etienne1, Saar Baert5, Helen Bygrave5
Factors associated with loss to follow up in a primary healthcare clinic practicing test and treat Authors: Julius Kiwanuka1,2, Noah Kiwanuka3, Flavia.
Differentiated Monitoring & Evaluation
How differentiated care supports “Tx all” and Dr
Durban, July 20th 2016 Ruggero Giuliani MSF - Mozambique
Differentiated service delivery: Youth perspectives
Peeramon Ningsanond MD. Bureau of AIDS TB STI, DDC, MOPH Thailand
2017 Key Considerations for adolescents and children & Key populations
ROUTINE HEALTH INFORMATION SYSTEMS
L.F. Jefferys1, J. Hector1, M.A. Hobbins2, J. Ehmer2, N. Anderegg3
Simple assessments of adherence to antiretorviral therapy predict virologic failure in HIV+ patients in Lusaka, Zambia Ronald A. Cantrell, MPH University.
MHEALTH to Improve Health: Effectiveness of a weekly text messaging intervention to improve ART adherence and HIV Viral Load: WelTel OAKTREE. M.C.M. Murray1,2,3,
Implementation of the Appointment Spacing Model of Differentiated Service Delivery in Ethiopia: Successes and Challenges Tamrat Assefa1, Zenebe Melaku1,
Dr. Velephi Okello, Principal Investigator, MaxART Trial
Retention: What It Means for You
Community ART for Retention in Zambia: Fast Track Model
Stakeholder engagement and research utilization: Insights from Namibia
Presentation transcript:

Press Briefing: Office of the Vice Chancellor MUK 6 th September 2010 The Infectious Diseases Institute Care and Research Initiatives Dr Alex G Coutinho Executive Director IDI-MUCHS

Press Briefing: Office of the Vice Chancellor MUK 6 th September 2010 IDI’s Contribution to the National HIV/AIDS Care and Treatment Response The Care and Treatment Services at Mulago –9,000 active clients in care –6,500 active clients on antiretroviral therapy (ART) –600 active clients on second-line ART The KCC-IDI Project –HIV/AIDS care capacity established at 6 KCC Health centres –5,000 active clients in care –2,500 active clients on antiretroviral therapy

Press Briefing: Office of the Vice Chancellor MUK 6 th September 2010 PCT Programme Innovations Internally-focused Innovations (task-shifting) –Nurse visit programme –Pharmacy- refill visit programme –Use of HIV+ friends to support clinic flow –Computerization of medical records (ICEA) Externally-focused Innovations –Development of care capacity in the Kampala city council facilities –Development of care and treatment capacity in 7 districts in North- West Uganda

Press Briefing: Office of the Vice Chancellor MUK 6 th September 2010 Summary of the Task-shifting Approach: ART REFILLS -Protocol WHO stage 3 or 4 CD4 count less than 200cells/ul On ART Stable At least 4 nurse visits Criteria: Assessed by MO Adherence to ART 100% Disclosure Regular appointments for 6/12 Not pregnant No ART toxicity grade 3/4 Agrees to refill CD4 rising Cohort: undetectable viral load Counseling Reinforce adherence message for refill Prescription by the doctor for Two refills Mo 1 Refill 1 Mo 2 Refill 2 Mo 3 3 monthly routine nurse visits: History and assessment Prescription by Nurse/ Doctor I/c Nurse visit Lab-request for lab-file Mo 4 Refill 1 Mo 5 Refill 2 Blood taking 6 monthly doctors visit with CD4 results and assessment Good adherence & good response to therapy¹ 6 MONTH CYCLE

Press Briefing: Office of the Vice Chancellor MUK 6 th September 2010 Evolution of the PCT Key Performance Indicators

Press Briefing: Office of the Vice Chancellor MUK 6 th September 2010 Using ICTs to improve Programme Quality ICEA.net (Clinic Database) On-line prescriptions and lab requisitions fully functional Clinical dashboards for user friendly access to clinical information Automatic downloads of lab results The ICEA Client Interface for Clinicians

Press Briefing: Office of the Vice Chancellor MUK 6 th September 2010 AIDC Numbers in the National Context

Press Briefing: Office of the Vice Chancellor MUK 6 th September 2010 IDI Research Programme Summary Programme goal is to cultivate African-led research 97 publications in peer- reviewed journals by June 2010 Over 40 research projects currently active

Press Briefing: Office of the Vice Chancellor MUK 6 th September 2010 Late Presentation increases mortality in HIV-infected subjects on ART

Press Briefing: Office of the Vice Chancellor MUK 6 th September 2010 Cumulative probability of death over 36 months on ART according to CD4 cell count stratum with the highest mortality rates realized in those with CD4 T cell counts<25 cells/μL. Probability of death Early Mortality in ART Cohorts is Dependant on Baseline CD4 Count

Press Briefing: Office of the Vice Chancellor MUK 6 th September 2010 Planned Research Studies to investigate how to reduce early mortality in HIV treatment 1.Prevention of Early Mortality Study in a district setting (Kiboga District Hospital) 2.The PROMPT Study on prevention of early mortality among TB co-infected HIV patients

Press Briefing: Office of the Vice Chancellor MUK 6 th September 2010 Acknowledgements Makerere University The Ministry of Health- Uganda College of Health Sciences –Prof Moses Kamya –Prof Harriet Mayanja –Prof Elly Katabira IDI Management / Staff CDC/PEPFAR IDI Clients